MedPath
NMPA Approval

Polaprezinc Granules

国药准字H20253401

February 20, 2025

Drug Information

聚普瑞锌颗粒

颗粒剂

75mg

化学药品

February 20, 2025

Company Information

Applicant Company

江苏省盐城市大丰区南翔西路266号

Manufacturing Company

江苏省盐城市大丰区健康东路103号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.